MARKET

EDAP

EDAP

Edap Tms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.61
+0.20
+2.70%
Opening 10:35 03/08 EST
OPEN
7.42
PREV CLOSE
7.41
HIGH
7.68
LOW
7.12
VOLUME
56.34K
TURNOVER
--
52 WEEK HIGH
10.68
52 WEEK LOW
1.460
MARKET CAP
221.77M
P/E (TTM)
-54.4739
1D
5D
1M
3M
1Y
5Y
EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US
Initiatives focused on making HIFU procedures broadly accessible to both Medicare and commercially insured patients LYON, France, March 3, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announces to...
GlobeNewswire · 5d ago
Tumor Ablation Market Sales and Revenue by Companies, Regions, Type and Application till 2027 | ARC
pune, India, Tue, 23 Feb 2021 01:57:16 / Comserve Inc. / -- The global tumor ablation market size is anticipated to reach around USD 3.2 bn by 2026, with...
Comserve · 02/23 06:59
Global Tumor Ablation Market Is Expected to Reach USD 1,634 Million by 2028 : Fior Markets
Newark, NJ, Feb 18, 2021 (GLOBE NEWSWIRE via COMTEX) -- Newark, NJ, Feb. 18, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global...
GlobeNewswire · 02/19 00:00
Europe Tumor Ablation Market Research Report by Type, by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19
Feb 17, 2021 (Heraldkeepers) -- The scope of the report includes a detailed study of Europe and regional markets on Europe Tumor Ablation Market with the...
Heraldkeepers · 02/17 13:14
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11)
Benzinga · 02/11 12:26
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10)
Benzinga · 02/10 12:34
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 9)
Benzinga · 02/09 13:10
Ablation Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
Feb 09, 2021 (Market Insight Reports) -- The Ablation Devices research is an astute report with intricate details for studying appropriate parameters and...
Market Insight Reports · 02/09 11:41
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EDAP. Analyze the recent business situations of Edap Tms through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EDAP stock price target is 12.41 with a high estimate of 14.70 and a low estimate of 9.80.
EPS
Institutional Holdings
Institutions: 49
Institutional Holdings: 5.11M
% Owned: 17.55%
Shares Outstanding: 29.14M
TypeInstitutionsShares
Increased
6
94.90K
New
10
580.41K
Decreased
6
441.24K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.32%
Healthcare Equipment & Supplies
+0.94%
Key Executives
Chairman/Chief Executive Officer/Director
Marc Oczachowski
Chief Financial Officer
Francois Dietsch
Director
Marie Meynadier
Independent Director
Pierre Beysson
Independent Director
Robrecht Michiels
Independent Director
Rob Michiels
Independent Director
Argil Wheelock
No Data
About EDAP
EDAP TMS S.A. (EDAP) is a company that develops, manufactures, promotes and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. The Company operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The Company invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The Company is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The Company is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

Webull offers kinds of Edap Tms SA (ADR) stock information, including NASDAQ:EDAP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDAP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EDAP stock methods without spending real money on the virtual paper trading platform.